State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

INTRODUCTION: The extreme health and economic problems in the world due to the SARS-CoV-2 infection have led to an urgent need to identify potential drug targets for treating coronavirus disease 2019 (COVID-19). The present state-of-the-art tool-based screening was targeted to identify drug targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgio, J. Francis, Alsuwat, Hind Saleh, Al Otaibi, Waad Mohammed, Ibrahim, Abdallah M., Almandil, Noor B, Al Asoom, Lubna Ibrahim, Salahuddin, Mohammed, Kamaraj, Balu, AbdulAzeez, Sayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212215/
https://www.ncbi.nlm.nih.gov/pubmed/32399096
http://dx.doi.org/10.5114/aoms.2020.94567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212215/
https://www.ncbi.nlm.nih.gov/pubmed/32399096
http://dx.doi.org/10.5114/aoms.2020.94567

Ejemplares similares